Cinepazide maleate belongs to calcium channel blockers, with the effect of vasodilatation, used for cerebral atherosclerosis as well as insufficient perfusion of cerebral arteries, cerebral vasospasm state, as well as used for retinal hemorrhage, craniocerebral injuries, sequelae of traumatic brain injuries, and the recovery period after brain surgery. In cardiovascular is also widely used, such as for arteriosclerosis, cerebral infarction, angina pectoris, myocardial infarction, use should be used in conjunction with other related drugs. It is also effective in the treatment of various trauma fractures. Microcirculation disorders caused by diabetes mellitus, such as diabetic foot, neuropathy, retinopathy, etc., can also be clinically applied to the treatment of the drug. Other diseases can also be applied, such as atherosclerosis of the lower limbs, thromboembolic vasculitis, and Raynaud’s disease, arteritis and other vascular diseases.